n(6)-carboxymethyllysine has been researched along with Disease Models, Animal in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Bian, Y; Hishikawa, N; Matsumoto, N; Nomura, E; Ohta, Y; Omote, Y; Sasaki, R; Shang, J; Tadokoro, K; Taira, Y; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
| Ahmad, S; Akashah, R; Alouffi, S; Faisal, M; Khan, M; Khan, MS; Khan, S; Shahab, U | 1 |
| Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J | 1 |
| Blasetti Fantauzzi, C; Cappello, P; de Latouliere, L; Iacobini, C; Ionta, V; Manni, I; Menini, S; Novelli, F; Pesce, C; Piaggio, G; Pugliese, G | 1 |
| Ahmad, S; Khan, H; Khan, MS | 1 |
| Böhm, M; Ewen, S; Hohl, M; Kazakov, A; Kindermann, I; Laufs, U; Linz, D; Mahfoud, F; Selejan, SR; Speer, T; Tatu, AM; Zamyatkin, O | 1 |
| Kabata, K; Matsuda, S; Nagai, R; Shirakawa, JI; Sugawa, H | 1 |
| Abe, K; Fukui, Y; Hishikawa, N; Inufusa, H; Kusaki, M; Liu, X; Morihara, R; Nakano, Y; Ohta, Y; Sato, K; Shang, J; Takemoto, M; Tian, F; Yamashita, T | 1 |
| Eriksson, UJ; Gittenberger-de Groot, AC; Molin, DG; Roest, PA; Schalkwijk, CG; van Iperen, L; Wentzel, P | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T; Ozawa, Y | 1 |
| Bianchi, ME | 1 |
| Agbaje, I; Czerwiec, A; Glenn, J; Mallidis, C; McClure, N; O'Neill, J; Stitt, A | 1 |
| Choi, YG; Lim, S | 1 |
| Czerwiec, A; Filippi, S; Maggi, M; Mallidis, C; McClure, N; O'Neill, J | 1 |
| Barnham, KJ; Hatsuta, H; Irie, K; Kaneko, T; Kinoshita, N; Murakami, K; Murata, N; Murayama, S; Noda, Y; Shimizu, T; Shirasawa, T; Tahara, S | 1 |
| Chang, CT; Chang, YM; Chen, SM; Huang, TC; Huang, YP; Lee, JA; Li, YC; Tsai, SH | 1 |
| Aoyama, I; Enomoto, A; Nakamura, S; Niwa, T; Tachikawa, T; Takayama, F; Tobita, K | 1 |
| Busch, AE; Huber, J; Linz, W; Rütten, H; Schäfer, S; Wihler, C | 1 |
| Andrassy, M; Autschbach, F; Bierhaus, A; Chen, J; Humpert, PM; Igwe, J; Katus, HA; Kientsch-Engel, R; Liliensiek, B; Morcos, M; Nawroth, PP; Neurath, MF; Remppis, A; Schiekofer, S; Schleicher, E; Schmidt, AM; Stern, DM; Stremmel, W; Thiele, K; Volz, C; Wendt, T | 1 |
| Heine, RJ; Niessen, HW; Schalkwijk, CG; Simsek, S; van Deutekom, AW | 1 |
| Kelly, FJ; Lubec, G | 1 |
| Hermon, M; Hoeger, H; Lubec, B; Lubec, G | 1 |
| Ando, A; Fukunaga, M; Hori, M; Imai, E; Kawada, N; Kurokawa, K; Miyata, T; Moriyama, T | 1 |
| Schmidt, AM; Stern, DM; Yan, SD; Yan, SF | 1 |
| Lalla, E; Lamster, IB; Schmidt, AM; Stern, DM | 1 |
2 review(s) available for n(6)-carboxymethyllysine and Disease Models, Animal
| Article | Year |
|---|---|
The biology of the receptor for advanced glycation end products and its ligands.
Topics: Amyloidosis; Animals; Capillary Permeability; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Glycation End Products, Advanced; Humans; Ligands; Lung; Lysine; Membrane Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Amyloid A Protein; Tumor Cells, Cultured | 2000 |
Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
Topics: Alveolar Bone Loss; Animals; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Glycation End Products, Advanced; Hyperglycemia; Immunoglobulins; Ligands; Lysine; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Periodontal Diseases; Periodontitis; Phagocytes; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2001 |
23 other study(ies) available for n(6)-carboxymethyllysine and Disease Models, Animal
| Article | Year |
|---|---|
Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Antioxidants; Brain; Cinnamates; Depsides; Dietary Supplements; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lysine; Male; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Rosmarinic Acid | 2020 |
Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An
Topics: Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycation End Products, Advanced; Glycosylation; Gold; Guanidines; Lysine; Male; Metal Nanoparticles; Proteins; Pyruvaldehyde; Rats; Rats, Wistar | 2021 |
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells | 2018 |
The advanced glycation end-product N
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Diabetes Complications; Disease Models, Animal; Disease Progression; Genes, ras; Humans; Lysine; Mice, Inbred C57BL; Mice, Transgenic; Pancreatic Neoplasms; Peptides; Receptor for Advanced Glycation End Products; Risk Factors; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
The in vivo and in vitro approaches for establishing a link between advanced glycation end products and lung cancer.
Topics: A549 Cells; Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Humans; Lung Neoplasms; Lysine; Male; Mice; Protein Carbonylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor for Advanced Glycation End Products | 2018 |
Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Topics: ADAM10 Protein; Analysis of Variance; Animals; Denervation; Disease Models, Animal; Fibroblasts; HMGB1 Protein; Hypertension; Kidney; Leukocytes, Mononuclear; Ligands; Lysine; Male; Metabolic Syndrome; Myocardium; Obesity; Protein Isoforms; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Adrenergic, beta; Statistics, Nonparametric; Sympathetic Nervous System; Up-Regulation | 2018 |
[Preventive Effects of Aphanothece sacrum on Diabetic Cataracts].
Topics: Animals; Cataract; Cyanobacteria; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Glycation End Products, Advanced; Lens, Crystalline; Lysine; Male; Mice, Inbred Strains; Oxidative Stress; Streptozocin; Tandem Mass Spectrometry | 2019 |
Neuroprotective Effects of a Novel Antioxidant Mixture Twendee X in Mouse Stroke Model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Brain; Deoxyguanosine; Disease Models, Animal; Glycation End Products, Advanced; Infarction, Middle Cerebral Artery; Inflammation Mediators; Lysine; Male; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Time Factors | 2017 |
Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.
Topics: Animals; Congenital Abnormalities; Disease Models, Animal; Embryo, Mammalian; Female; Glycation End Products, Advanced; Heart Defects, Congenital; Humans; Infant, Newborn; Lysine; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley; Risk Factors; Smad2 Protein; Vascular Endothelial Growth Factor A; Wound Healing | 2009 |
Effect of N-epsilon-(carboxymethyl)lysine on coronary vasoconstriction in isolated perfused hearts from control and streptozotocin-induced diabetic rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Calcium Channels; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Drug Synergism; Glycation End Products, Advanced; In Vitro Techniques; Lysine; Male; Rats; Rats, Wistar; Stimulation, Chemical; Streptozocin; Superoxides; Vasoconstriction | 2009 |
Editorial: A recipe for inflammation.
Topics: Animals; Disease Models, Animal; Humans; Inflammation; Lysine; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Albumin | 2009 |
Differences in mouse models of diabetes mellitus in studies of male reproduction.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA Damage; Epididymis; Glycation End Products, Advanced; Infertility, Male; Lysine; Male; Mice; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Spermatozoa; Streptozocin; Testis | 2010 |
N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glycation End Products, Advanced; Lysine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase | 2010 |
Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism.
Topics: Animals; Dietary Fats; Disease Models, Animal; DNA Fragmentation; Epididymis; Glycation End Products, Advanced; Gonadotropin-Releasing Hormone; Hyperglycemia; Hypogonadism; Lysine; Male; Metabolic Syndrome; Rabbits; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Semen Analysis; Spermatogenesis; Spermatozoa; Testis; Triptorelin Pamoate | 2011 |
SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Enzyme Activation; Glycation End Products, Advanced; Humans; Inflammation; Lysine; Memory Disorders; Mice; Mice, Knockout; Neurons; Oxidation-Reduction; Protein Multimerization; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides | 2011 |
Aristolochic acid-induced accumulation of methylglyoxal and Nε-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy.
Topics: Animals; Aristolochic Acids; Creatine; Disease Models, Animal; Female; Kidney; Lysine; Mice; Mice, Inbred C3H; Nephritis, Interstitial; Pyruvaldehyde | 2012 |
An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Topics: Age Factors; Animals; Antibodies, Monoclonal; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Rats; Rats, Inbred OLETF; Rats, Inbred Strains; Thiadiazoles; Thiazolidines | 2003 |
Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine.
Topics: Animals; Biomarkers; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Lysine; Male; Myocardial Contraction; Myocardium; Rats; Rats, Zucker; Severity of Illness Index; Ventricular Dysfunction, Left | 2006 |
Posttranslationally modified proteins as mediators of sustained intestinal inflammation.
Topics: Adult; Animals; Calgranulin A; Calgranulin B; Cell Extracts; Disease Models, Animal; Endothelial Cells; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Lysine; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2006 |
Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Brain; Cerebrovascular Circulation; Child; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Rats; Rats, Wistar | 2008 |
Hyperoxic injury of immature guinea pig lung is mediated via hydroxyl radicals.
Topics: Animals; Animals, Newborn; Body Weight; Disease Models, Animal; Female; Guinea Pigs; Hydroxyl Radical; Hyperoxia; Lung; Lung Diseases; Lysine; Male; Oxidative Stress; Pregnancy; Survival Rate; Tyrosine | 1995 |
Aromatic hydroxylation in animal models of diabetes mellitus.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fructosamine; Hydroxylation; Kidney; Lysine; Malondialdehyde; Mice; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Streptozocin; Tyrosine | 1998 |
Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction.
Topics: Animals; Disease Models, Animal; Fibrosis; Glycation End Products, Advanced; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Immunohistochemistry; Kidney; Lysine; Male; Membrane Proteins; Mice; Oxidative Stress; RNA, Messenger; Ureteral Obstruction | 1999 |